ExecPay

Maiken Keson-Brookes

Overview202120202019

Overview

Maiken Keson-Brookes received an average of $1M in total compensation, including $288K in salary, at Rubius Therapeutics from 2019 to 2021.

Source: SEC filing on March 30, 2022.
Keson-Brookes' 2021 pay

Related executives

We found five more executives who work or worked at Rubius Therapeutics.

Pablo Cagnoni

Rubius Therapeutics

Chief Executive Officer

3

Dannielle Appelhans

Rubius Therapeutics

Chief Operating Officer

1

Laurence Turka

Rubius Therapeutics

Chief Scientific Officer

2

Jose Carmona

Rubius Therapeutics

Chief Financial Officer

1

Christina Coughlin

Rubius Therapeutics

Chief Medical Officer

1

News

You may also like

Rubius Therapeutics